Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04514549 · ClinicalTrials.gov registry record

ASSESSING EMERALD AND MC10 BIOSTAMP nPOINT BIOSENSORS FOR RETT SYNDROME

A clinical trial of Rett Syndrome, sponsored by Rett Syndrome Research Trust.

Completed
Registry status
21
Enrollment target
1
Study location

NCT04514549 is a study of Rett Syndrome that has completed, run by Rett Syndrome Research Trust. The registered enrollment target is 21 participants, below the 525-participant average among 18 other Rett Syndrome trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04514549, a study of Rett Syndrome, has completed, sponsored by Rett Syndrome Research Trust.

COMPLETED
Registry status
21 participants
Enrollment target
1
Study location

Study Summary

This is a pilot study of the Emerald device in Rett syndrome patients diagnosed with a confirmed MECP2 mutation. MC10 BioStamp nPoint patches will also be assessed with the goal to develop Rett-specific breathing algorithms

Conditions Studied

Rett Syndrome

Interventions

  • DEVICE Emerald

Study Locations (1)

Massachusetts

  • Boston Children's Hospital - Boston

Trial Details

FieldValue
Enrollment Target 21 participants
Start Date 2020-11-23
Est. Completion 2023-03-01

Sponsor

Rett Syndrome Research Trust

5 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04514549

The ClinicalTrials.gov registry entry for NCT04514549 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 525-participant average among 18 other Rett Syndrome trials with a reported enrollment target (96% lower). The listed sponsor is Rett Syndrome Research Trust, which has 5 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Rett Syndrome appearing as the primary indexed condition, and to 1 intervention - of which Emerald is the first listed.

NCT04514549 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT04514549 about?

NCT04514549 is a clinical study titled "ASSESSING EMERALD AND MC10 BIOSTAMP nPOINT BIOSENSORS FOR RETT SYNDROME". This is a pilot study of the Emerald device in Rett syndrome patients diagnosed with a confirmed MECP2 mutation. MC10 BioStamp nPoint patches will also be assessed with the goal to develop Rett-specific breathing algorithms

What is the current status of trial NCT04514549?

This trial is currently completed. The enrollment target is 21 participants. The study started on 2020-11-23. Estimated completion is 2023-03-01.

What conditions does trial NCT04514549 study?

This clinical trial studies the following conditions: Rett Syndrome.

What interventions are being tested in trial NCT04514549?

The interventions under investigation include: Emerald (DEVICE).

Who is sponsoring clinical trial NCT04514549?

This trial is sponsored by Rett Syndrome Research Trust, which has 5 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04514549 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Rett Syndrome

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Rett Syndrome

All registered trials for this condition

Massachusetts

All trials with a study site in Massachusetts

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.